PROXY STATEMENT

Company

ORAMED PHARMACEUTICALS INC.

Filed

July 16, 2025

Period of Report

August 19, 2025

Accession Number

0001213900-25-064755

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →